CBS Money Watch
· Feb 18, 2026 4:49 PM EST
Not market news
Moderna says FDA to review its flu vaccine after reversing course
With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
